Riboksin refers to the drug class that controls the mechanism of metabolism. The product is a precursor of purine nucleotide synthesis: triphosphate for adenosine and triphosphate of guanosine. The drug's active substance is Inosine.
HOW IT WORKS:
Riboksin actively engages in the movement of glucose and encourages metabolism activation under hypoxic circumstances and in the vicinity of ATP. Riboksin facilitates the synthesis of pyruvic acid. The medication facilitates nucleotide synthesis, improves the activity of certain Krebs cycle enzymes.
Riboksin enhances complex diagnosis of coronary heart disease, heart rhythm disturbances, cardiac glycoside preparation poisoning, cardiomyopathy treatment with different genes, and heart disease.
The riboksin contains tablets of 200mg. Before taking this prescription, always consult your doctor as sometimes riboksin can be injected into the body. You can take Riboksin with or without a meal.
Before food, the drug is used inwardly.
The adult daily dose of riboksin is set separately and is 0.5-2.6g per day. A medicine is usually prescribed at the start of therapy at a daily dose of 0.2-0.4g (1 tablet 1-2 times daily). The dosage is gradually increased (within 2-4 days) to 1.4 g per day (2 tablets 2 times per day) in the case of good tolerability.
The side-effects include headache, skin itching, disability, sleeping disorder, nausea and skin diseases.